Mutational analysis of human tumor necrosis factor-α

Biotechnology Letters

Volumn 27, Issue 2, 2005, Pages 107-112

  Shin, Hang Cheol ^a   Cho, Kwang Hwi ^a  

^a Soongsil University   (South Korea)

Author keywords

Cytotoxicity; Muteins; Receptor binding; Structure function relationship; Tumor necrosis factor

Indexed keywords

CELLS; MUTAGENESIS; PURIFICATION; TOXICITY; TUMORS;

MUTATIONAL ANALYSIS; MUTEINS; NECROSIS; THERAPEUTIC AGENTS;

DISEASES;

TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL; ARTICLE; BINDING SITE; CELL CULTURE; CHEMICAL STRUCTURE; CHEMISTRY; FIBROSARCOMA; GENETICS; HUMAN; MOLECULAR GENETICS; MOUSE; MUTATION; PROTEIN CONFORMATION; STRUCTURE ACTIVITY RELATION; TOXICITY TESTING;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; BINDING SITES; FIBROSARCOMA; HUMANS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP; TOXICITY TESTS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE;

EID: 14644408128     PISSN: 01415492     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10529-004-6937-y     Document Type: Article

References (23)

1. Borsi L, Balza E, Carnemolla B, Sassi F, Castellani P, Bernt A, Kosmehl H, Biro A, Siri A, Orecchia P, Grassi J, Neri D, Zardi L (2003) Selective targeted delivery of TNF-α to tumor blood vessels. Blood 102: 4384-4392.
2. Cha SS, Kim MS, Choi YH, Sung BJ, Shin NK, Shin HC, Sung YC, Oh BH (1999) 2.8 Å resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity. Immunity 11: 253-261.
3. Corti A (2004) Strategies for improving the anti-neoplastic activity of TNF by tumor targeting. Methods Mol. Med. 98: 247-264.
4. Cosman D (1994) A family of ligands for the TNF receptor superfamily. Stem Cells 12: 440-455.
5. Creasey AA, Doyle LV, Reynolds MT, Jung T, Lin LS, Vitt CR (1987) Biological effects of recombinant human tumor necrosis factor and its novel muteins on tumor and normal cell lines. Cancer Res. 47: 145-149.
6. Eck MJ, Ultsch M, Rinderknecht E, de Vos AM, Sprang SR (1992) The structure of human lymphotoxin (tumor necrosis factor-beta) at 1.9-Å resolution. J. Biol. Chem. 267: 2119-2122.
7. Engelmann H, Holtmann H, Brakebusch C, Avni YS, Sarov I, Nophar Y, Hadas E, Leitner O, Wallach D (1990) Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J. Biol. Chem. 265: 14497-14504.
8. Espevik T, Prockhaus M, Loetscher H, Norstad U, Schalaby MR (1990) Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor. J. Exp. Med. 171: 415-426.
9. Fiers W (1991) Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett. 285: 199-212.
10. Gatanaga T, Noguchi K, Tanabe Y, Inagawa H, Soma GI, Mizino D (1989) Antitumor effect of systemic administration of novel recombinant tumor necrosis factor (rTNF-S) with less toxicity than conventional rTNF-alpha in vivo. J. Biol. Response Mod. 8: 278-286.
11. Jeong W, Shin NK, Shin, HC (1997) Bacterial chaperones increase the production of soluble human TNF-alpha in Escherichia coli. Biotechnol Lett. 19: 579-582.
12. Jones EY, Stuart DI, Walker NP (1989) Structure of tumor necrosis factor. Nature 338: 225-228.
13. Kamijo R, Takeda K, Nagumo M, Konno K, Hasegawa A, Inaka K, Ikehara M (1989) Induction of differentiation of human monoblastic and myeloblastic leukemia cell lines by TNF muteins. Biochem. Biophys. Res. Commun. 160: 820-827.
14. Karpusas M, Hsu YM, Wang J, Thomson J, Lederman S, Chess L, Thomas D (1995) 2 Å crystal crystal structure of an extracellular fragment of human CD40 ligand. Structure 3: 1031-1039.
15. Loetscher H, Steinmetz M, Lesslauer W (1991) Tumor necrosis factor: receptors and inhibitors. Cancer Cells 3: 221-226.
16. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55-63.
17. Nakamura S, Kato A, Masegi T, Fukuoka M, Kitai K, Ogawa H, Ichigawa Y, Maeda M, Watanabe N, Niitsu Y (1991) A novel recombinant tumor necrosis factor-alpha mutant with increased anti-tumor activity and lower toxicity. Int. J. Cancer 48: 744-748.
18. Shalaby MR, Sundan A, Loetscher H, Brockhaus M, Lesslauer W, Espevik T (1990) Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors. J. Exp. Med. 172: 1517-1520.
19. Tartaglia LA, Goeddel DV (1992) Two TNF receptors. Immunol. Today 13: 151-153.
20. Tartaglia LA, Weber RF, Figari IS, Reymonds C, Palladino Jr MA, Goeddel DV (1991) The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. USA 88: 9292-9296.
21. Van Ostade X, Tavernier J, Fiers W (1994) Structure-activity studies of human tumour necrosis factors. Protein Eng. 7: 5-22.
22. Van Ostade X, Tavernier J, Prange T, Fiers W (1991) Localization of the active site of human tumour necrosis factor (hTNF) by mutational analysis. EMBO J. 10: 827-836.
23. Zhang XM, Weber I, Chen MJ (1992) Site-directed mutational analysis of human tumor necrosis factor-alpha receptor binding site and structure-functional relationship. J. Biol. Chem. 267: 24069-24075.